Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15774 articles
Sotorasib for Lung Cancers with
KRAS
p.G12C Mutation.
Sotorasib therapy led to durable clinical benefit.
»
06/08/21
Mixed and nonvaccine high risk HPV types are associated with higher mortality in Black women with cervical cancer.
High proportion of cervical cancer cells in our patients expressed PD-L1.
»
01/04/21
Associations between frailty and cancer-specific mortality among older women with breast cancer.
Degree of frailty not associated with BC-specific mortality.
»
04/07/21
Proton Beam Therapy for Local Recurrence of Rectal Cancer.
No severe acute or late adverse events.
»
02/04/21
Feasibility and Biological Activity of a Ketogenic/Intermittent-Fasting Diet in Patients With Glioma.
Average ketonuria correlated with cerebral ketones in lesional (tumor) and contralateral brain.
»
11/13/20
Association of the Healthy Nordic Food Index with risk of bladder cancer: a case-control study.
Significant negative association observed for fish intake.
»
03/25/21
Stereotactic body radiation therapy for the treatment of localized prostate cancer in men with underlying inflammatory bowel disease
Modern radiation techniques appear to have mitigated risk of GI side effects.
»
07/09/21
The value of restaging CT following neoadjuvant chemotherapy for resectable gastric cancer. A population-based study
Restaging CT with response evaluation not able to stratify patients into groups of different long-term survival rates.
»
07/13/21
Complete response to neoadjuvant chemoradiotherapy in rectal cancer is associated with RAS/AKT mutations and high tumour mutational burden
No significant differences in tumour heterogeneity as measured by MATH score.
»
07/13/21
Quality-adjusted Time Without Symptoms of disease or Toxicity (Q-TWiST) analysis of CPX-351 versus 7 + 3 in older adults with newly diagnosed high-risk/secondary AML
CPX-351 improved quality-adjusted survival.
»
07/13/21
< Prev
Next >